Sustained exenatide delivery via intracapsular microspheres for improved survival and function of microencapsulated porcine islets

Benjamin Lew, In Yong Kim, Hyungsoo Choi, Kyekyoon Kim

Research output: Contribution to journalArticle

Abstract

The ability of glucagon-like peptide-1 analogs to enhance glucose-dependent insulin secretion and to inhibit β cell apoptosis could be of potential benefit for islet transplantation. In this study, we investigated the effect of sustained local delivery of exenatide, a synthetic exendin-4, on the in vitro viability and function of encapsulated porcine islets. Prior to encapsulation, we fabricated exenatide-loaded poly(latic-co-glycolic acid) microspheres, and investigated their release behavior with different initial drug-loading amounts. Exenatide-loaded microspheres, exhibiting a sustained release over 21 days, were subsequently chosen and co-encapsulated with porcine islets in alginate microcapsules. During the 21-day period, the islets co-encapsulated with the exenatide-loaded microspheres exhibited improved survival and glucose-stimulated insulin secretion, compared to those without. This suggested that the intracapsular sustained delivery of exenatide via microspheres could be a promising strategy for improving survival and function of microencapsulated porcine islets for islet xenotransplantation.

Original languageEnglish (US)
Pages (from-to)857-862
Number of pages6
JournalDrug Delivery and Translational Research
Volume8
Issue number3
DOIs
StatePublished - Jan 25 2018

Fingerprint

Microspheres
Swine
glycolic acid
Insulin
Glucose
Islets of Langerhans Transplantation
Heterologous Transplantation
Glucagon-Like Peptide 1
Capsules
exenatide
Apoptosis
Pharmaceutical Preparations

Keywords

  • Exenatide
  • Islet encapsulation
  • Islet xenotransplantation
  • Microcapsules
  • Microspheres
  • Porcine islets

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Sustained exenatide delivery via intracapsular microspheres for improved survival and function of microencapsulated porcine islets. / Lew, Benjamin; Kim, In Yong; Choi, Hyungsoo; Kim, Kyekyoon.

In: Drug Delivery and Translational Research, Vol. 8, No. 3, 25.01.2018, p. 857-862.

Research output: Contribution to journalArticle

@article{81a1d7c9ae1c47cfaa07052961176bde,
title = "Sustained exenatide delivery via intracapsular microspheres for improved survival and function of microencapsulated porcine islets",
abstract = "The ability of glucagon-like peptide-1 analogs to enhance glucose-dependent insulin secretion and to inhibit β cell apoptosis could be of potential benefit for islet transplantation. In this study, we investigated the effect of sustained local delivery of exenatide, a synthetic exendin-4, on the in vitro viability and function of encapsulated porcine islets. Prior to encapsulation, we fabricated exenatide-loaded poly(latic-co-glycolic acid) microspheres, and investigated their release behavior with different initial drug-loading amounts. Exenatide-loaded microspheres, exhibiting a sustained release over 21 days, were subsequently chosen and co-encapsulated with porcine islets in alginate microcapsules. During the 21-day period, the islets co-encapsulated with the exenatide-loaded microspheres exhibited improved survival and glucose-stimulated insulin secretion, compared to those without. This suggested that the intracapsular sustained delivery of exenatide via microspheres could be a promising strategy for improving survival and function of microencapsulated porcine islets for islet xenotransplantation.",
keywords = "Exenatide, Islet encapsulation, Islet xenotransplantation, Microcapsules, Microspheres, Porcine islets",
author = "Benjamin Lew and Kim, {In Yong} and Hyungsoo Choi and Kyekyoon Kim",
year = "2018",
month = "1",
day = "25",
doi = "10.1007/s13346-018-0484-x",
language = "English (US)",
volume = "8",
pages = "857--862",
journal = "Drug Delivery and Translational Research",
issn = "2190-393X",
publisher = "Springer Publishing Company",
number = "3",

}

TY - JOUR

T1 - Sustained exenatide delivery via intracapsular microspheres for improved survival and function of microencapsulated porcine islets

AU - Lew, Benjamin

AU - Kim, In Yong

AU - Choi, Hyungsoo

AU - Kim, Kyekyoon

PY - 2018/1/25

Y1 - 2018/1/25

N2 - The ability of glucagon-like peptide-1 analogs to enhance glucose-dependent insulin secretion and to inhibit β cell apoptosis could be of potential benefit for islet transplantation. In this study, we investigated the effect of sustained local delivery of exenatide, a synthetic exendin-4, on the in vitro viability and function of encapsulated porcine islets. Prior to encapsulation, we fabricated exenatide-loaded poly(latic-co-glycolic acid) microspheres, and investigated their release behavior with different initial drug-loading amounts. Exenatide-loaded microspheres, exhibiting a sustained release over 21 days, were subsequently chosen and co-encapsulated with porcine islets in alginate microcapsules. During the 21-day period, the islets co-encapsulated with the exenatide-loaded microspheres exhibited improved survival and glucose-stimulated insulin secretion, compared to those without. This suggested that the intracapsular sustained delivery of exenatide via microspheres could be a promising strategy for improving survival and function of microencapsulated porcine islets for islet xenotransplantation.

AB - The ability of glucagon-like peptide-1 analogs to enhance glucose-dependent insulin secretion and to inhibit β cell apoptosis could be of potential benefit for islet transplantation. In this study, we investigated the effect of sustained local delivery of exenatide, a synthetic exendin-4, on the in vitro viability and function of encapsulated porcine islets. Prior to encapsulation, we fabricated exenatide-loaded poly(latic-co-glycolic acid) microspheres, and investigated their release behavior with different initial drug-loading amounts. Exenatide-loaded microspheres, exhibiting a sustained release over 21 days, were subsequently chosen and co-encapsulated with porcine islets in alginate microcapsules. During the 21-day period, the islets co-encapsulated with the exenatide-loaded microspheres exhibited improved survival and glucose-stimulated insulin secretion, compared to those without. This suggested that the intracapsular sustained delivery of exenatide via microspheres could be a promising strategy for improving survival and function of microencapsulated porcine islets for islet xenotransplantation.

KW - Exenatide

KW - Islet encapsulation

KW - Islet xenotransplantation

KW - Microcapsules

KW - Microspheres

KW - Porcine islets

UR - http://www.scopus.com/inward/record.url?scp=85054955086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054955086&partnerID=8YFLogxK

U2 - 10.1007/s13346-018-0484-x

DO - 10.1007/s13346-018-0484-x

M3 - Article

VL - 8

SP - 857

EP - 862

JO - Drug Delivery and Translational Research

JF - Drug Delivery and Translational Research

SN - 2190-393X

IS - 3

ER -